Sundin A - Search Results

1

Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Pavel M, Öberg K, Falconi M, Krenning EP, Sundin A, Perren A, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Pavel M, et al. Among authors: sundin a. Ann Oncol. 2020 Jul;31(7):844-860. doi: 10.1016/j.annonc.2020.03.304. Epub 2020 Apr 6. Ann Oncol. 2020. PMID: 32272208 Free article. No abstract available.

2

In vivo demonstration of enzyme activity in endocrine pancreatic tumors: decarboxylation of carbon-11-DOPA to carbon-11-dopamine.

Bergström M, Eriksson B, Oberg K, Sundin A, Ahlström H, Lindner KJ, Bjurling P, Långström B. Bergström M, et al. Among authors: sundin a. J Nucl Med. 1996 Jan;37(1):32-7. J Nucl Med. 1996. PMID: 8543997 Free article.

3

Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors.

Orlefors H, Sundin A, Ahlström H, Bjurling P, Bergström M, Lilja A, Långström B, Oberg K, Eriksson B. Orlefors H, et al. Among authors: sundin a. J Clin Oncol. 1998 Jul;16(7):2534-41. doi: 10.1200/JCO.1998.16.7.2534. J Clin Oncol. 1998. PMID: 9667275

4

[PET in neuroendocrine tumors].

Eriksson B, Orlefors H, Sundin A, Westlin JE, Bergström M, Långström B, Oberg K. Eriksson B, et al. Among authors: sundin a. Nord Med. 1998 Nov;113(9):308-12. Nord Med. 1998. PMID: 9835765 Swedish.

5

Positron emission tomography in neuroendocrine tumours.

Eriksson B, Orlefors H, Sundin A, Skogseid B, Långström B, Bergström M, Oberg K. Eriksson B, et al. Among authors: sundin a. Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S167-71. Ital J Gastroenterol Hepatol. 1999. PMID: 10604124 Review.

6

Demonstration of [11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography.

Sundin A, Eriksson B, Bergström M, Bjurling P, Lindner KJ, Oberg K, Långström B. Sundin A, et al. Nucl Med Biol. 2000 Jan;27(1):33-41. doi: 10.1016/s0969-8051(99)00085-2. Nucl Med Biol. 2000. PMID: 10755643

7

Use of PET in neuroendocrine tumors. In vivo applications and in vitro studies.

Eriksson B, Bergström M, Orlefors H, Sundin A, Oberg K, Långström B. Eriksson B, et al. Among authors: sundin a. Q J Nucl Med. 2000 Mar;44(1):68-76. Q J Nucl Med. 2000. PMID: 10932603 Review.

8

Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs.

Fjällskog ML, Sundin A, Westlin JE, Oberg K, Janson ET, Eriksson B. Fjällskog ML, et al. Among authors: sundin a. Med Oncol. 2002;19(1):35-42. doi: 10.1385/MO:19:1:35. Med Oncol. 2002. PMID: 12025889

9

The role of PET in localization of neuroendocrine and adrenocortical tumors.

Eriksson B, Bergström M, Sundin A, Juhlin C, Orlefors H, Oberg K, Långström B. Eriksson B, et al. Among authors: sundin a. Ann N Y Acad Sci. 2002 Sep;970:159-69. doi: 10.1111/j.1749-6632.2002.tb04422.x. Ann N Y Acad Sci. 2002. PMID: 12381551 Review.

10

Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo-tumor visualization using positron emission tomography with 11C-harmine.

Orlefors H, Sundin A, Fasth KJ, Oberg K, Långström B, Eriksson B, Bergström M. Orlefors H, et al. Among authors: sundin a. Nucl Med Biol. 2003 Aug;30(6):669-79. doi: 10.1016/s0969-8051(03)00034-9. Nucl Med Biol. 2003. PMID: 12900293 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

333 results

Search Page